Correlation Between Pfizer and Innovator Russell
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator Russell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator Russell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator Russell 2000, you can compare the effects of market volatilities on Pfizer and Innovator Russell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator Russell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator Russell.
Diversification Opportunities for Pfizer and Innovator Russell
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Innovator is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator Russell 2000 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Russell 2000 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator Russell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Russell 2000 has no effect on the direction of Pfizer i.e., Pfizer and Innovator Russell go up and down completely randomly.
Pair Corralation between Pfizer and Innovator Russell
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Innovator Russell. In addition to that, Pfizer is 1.9 times more volatile than Innovator Russell 2000. It trades about -0.09 of its total potential returns per unit of risk. Innovator Russell 2000 is currently generating about 0.15 per unit of volatility. If you would invest 3,663 in Innovator Russell 2000 on August 29, 2024 and sell it today you would earn a total of 273.00 from holding Innovator Russell 2000 or generate 7.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Innovator Russell 2000
Performance |
| Timeline |
| Pfizer Inc |
| Innovator Russell 2000 |
Pfizer and Innovator Russell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Innovator Russell
The main advantage of trading using opposite Pfizer and Innovator Russell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator Russell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Russell will offset losses from the drop in Innovator Russell's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Innovator Russell vs. Innovator Nasdaq 100 Power | Innovator Russell vs. Innovator MSCI Emerging | Innovator Russell vs. Innovator MSCI EAFE | Innovator Russell vs. Innovator SP 500 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |